MPMattie Christine Pawlowic

Mattie Christine Pawlowic

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Mattie Christine Pawlowic has a total of 119 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Phylogenomics of captured Cryptosporidium sequenced directly from patient samples identifies clade-specific genomic architecture and host-adapted lineages

    by E. V. C. Alves-Ferreira, A. Khan, M. D. Tettey, F. Ihara, H. Vogel, S. Botchie, I. Ayi, M. C. Pawlowic, G. Robinson, R. M. Chalmers, et al.

    Cryptosporidium causes diarrhea and high mortality in young children in Africa and southern Asia. Low oocyst counts in stool often limit whole-genome sequencing from clinical samples. Here, we enrich for Cryptosporidium genomic DNA directly from stool samples using 74,973 RNA baits (CryptoCap_75K; 8.2 Mb) derived from gene-rich areas (100% coding capacity) within the Cryptosporidium parvum genome. This method produces genome-wide sequence data with sufficient depth and breadth of coverage using as few as 25 oocysts, including divergent species such as Cryptosporidium ubiquitum . To minimize reference bias, we utilize a dual-mapping strategy that integrates reads aligned to both C. parvum and C. ubiquitum to capture lineage-specific variation. Phylogenetic networks, haplotypes, and admixture analyses identify three C. ubiquitum groups, A and B exclusive to humans, with B showing evidence of admixture, whereas C is zoonotic. Group-specific polymorphisms cluster within discrete genomic regions, suggesting conserved haploblocks associate with host adaptation. This capture-based genomics approach provides high-resolution insights into Cryptosporidium population genetics and lays the groundwork for studies of zoonotic transmission, anthroponosis, and GWAS directly from clinical material.

  • Open Access

    Mysterious girls: The biology of female Cryptosporidium parasites

    by Sarah Stevens, Peyton Goddard, Katelyn A. Walzer, Mattie Christine Pawlowic

  • Open Access

    Establishment of TaqMan Probe-based Molecular Detection and Quantification of Cryptosporidium Species in Ghana: Cohort Study in School-aged Children

    by Senyo K Botchie, Georgina I Djameh, Ato K Tetteh, Beatrice L Colon, Ross Bacchetti, Mattie Christine Pawlowic, Irene Ayi

    Background Cryptosporidiosis, caused by Cryptosporidium spp., causes diarrhoeal disease in both humans and animals globally. However, research and treatment for diarrhoeal disease in Africa are generally focused on viral and bacterial pathogens. We adopted quantitative PCR (qPCR) for improved identification of Cryptosporidium parasites from clinical and non-clinical samples in Ghana. Methodology In a cross-sectional surveillance study, human stool samples obtained from five study sites across Ghana were analysed using gel-based nPCR-RFLP and/or TaqMan probe-based qPCR for detection, genotyping, and quantitation of cryptosporidiosis. Results We analysed two sets of samples collected from children of both sexes ages ≤12 years. The first set of 168 samples was analysed by nPCR-RFLP (nested PCR-Restriction Fragment Length Polymorphism). We detected 60 Cryptosporidium spp . infections (35.7%) of which 39 were clinical patients (representing 23.2% of total sample size: 14.9% C. hominis ; 7.1% C. parvum; 0.6% each of C. meleagridis and C. baileyi ) and 21 were non-clinical (12.5% of sample size: 6.0% C. hominis and 6.5% C. parvum ). The second set of samples were collected from non-clinical settings from 92 children and analysed by TaqMan qPCR. We detected Cryptosporidium spp. infections in 28.3% of this population. This consisted of 7.6% C. parvum (approximately 10 3 oocysts/g faeces), 16.3% C. hominis (10 3 –10 6 , oocysts/g faeces), and 4.4% with C. parvum and C. hominis co-infections. More males were infected than females (17.4% vs 10.9%). The highest infections were among ages 5–8 years (18.5%) and the lowest 0–4 years (4.4%) . Conclusion From our studies, TaqMan qPCR emerged as more efficient than nPCR-RFLP in detecting C. parvum and C. hominis. Confirmation of other zoonotic Cryptosporidium spp. detected by nPCR-RFLP requires DNA sequencing. It is, therefore, recommended that the TaqMan qPCR system be adapted to enhance molecular epidemiological studies on cryptosporidiosis in Africa .

  • Open Access

    Cryptosporidium oocyst wall proteins are true components of the oocyst wall and COWP8 is not required for parasite transmission

    by Ross Bacchetti, Sarah Stevens, Leandro Lemgruber, Mariana Azevedo Gonzalez Oliva, Emma M. Sands, Konstantinos Alexandrou, Michele Tinti, Lee Robinson, Jack C. Hanna, Simona Seizova, et al.

    Cryptosporidiosis is a significant cause of diarrhoeal disease contributing to substantial morbidity and mortality for the immunocompromised and for young children, especially those who are malnourished. There are no vaccines and no effective treatments for these patients. Cryptosporidium parasites are transmitted as an oocyst, which is composed of a hardy oocyst wall that protects parasites in the environment. Oocysts are often waterborne, and are resistant to common water treatments, including chlorination. Little is understood about how the Cryptosporidium oocyst is constructed, its composition, and the how it resists chlorination. A family of nine Cryptosporidium Oocyst Wall Proteins (COWPs) is predicted from the genome. However, due to the technical challenges of working with this parasite in the laboratory, only cowp1 has been investigated to date. Using CRISPR/Cas9, fluorescent fusions were generated for the remaining members of the family, COWP s 2–9. Microscopy confirms that all COWP s localise to the oocyst wall. Further, COWP s 2–4 appear to localise specifically to the oocyst suture, the site from which parasites emerge from the oocyst during infection. Cowp 6 and 8 were observed to be expressed by female parasites. These proteins localise to puncta consistent with organelles called wall forming bodies. These organelles store and then secrete material to form the oocyst wall. Parasites lacking cowp8 produce viable oocysts that have typical oocyst morphology. Cowp8 knockout oocysts are transmissible under laboratory settings and readily infect immunocompromised mice. Biomechanical measurements determine that COWP8 is not required for the strength of the oocyst wall. This work confirms the role of cowp s in oocyst wall formation and sets a foundation for further exploration of the role of these proteins in transmission of Cryptosporidium parasites.


  • Open Access

    Tissue atlas of Cryptosporidium parvum infection reveals contrasts between the natural neonatal calf model and laboratory mouse models

    by Peyton Goddard, Thomas Tzelos, Beatrice L Colon, Paul M Bartley, Lee Robinson, Leandro Lemgruber, Michele Tinti, Grant Mj Hall, Sarah Stevens, Louise Gibbard, et al.

    Cryptosporidium is an apicomplexan parasite that causes diarrhoeal disease. The species C. parvum is zoonotic and causes significant morbidity and mortality for both humans and farm animals; most commonly, calves and lambs. A One Health approach that integrates human, animal and environmental health perspectives is required to tackle this disease. Current treatments are limited and ineffective, meaning there is an urgent need to develop new anti-cryptosporidials both for human and animal health. The neonatal calf model is a natural model of infection employed as a tool for drug discovery or generating parasite material. However, the model is seldom utilised to investigate host-parasite interaction. Fundamental information about this model, including the location of the parasite in the gut, is lacking. It is also unclear how the more commonly utilised immunocompromised mouse models of cryptosporidiosis compare to the neonatal calf model. To address this, we established an acute, moderate experimental C. parvum infection in neonatal calves. Using transgenic parasites, we created a tissue atlas of infection for neonatal calf gut and immunocompromised mouse models and mapped and quantified infection to draw robust comparisons between models. Cryptosporidium infection was observed at high levels throughout the neonatal calf gastrointestinal tract and was not limited to the ileal-cecal junction, as previously suggested. This infection pattern is most similar to the acute cryptosporidiosis mouse model, interferon-gamma knockout mice (IFNγKO). Infection with transgenic parasites allowed us to perform in vivo and ex vivo tissue imaging of the chronic cryptosporidiosis mouse model, NOD SCID Gamma KO (NSG) mice. In contrast, in NSG mice infection is low in the small intestines and highest in the caecum and colon. Understanding the true distribution of infection in the gastrointestinal tract of these three key animal models provides new perspectives on how to interpret and design drug efficacy studies and provides new insight into host-pathogen interaction.


  • Open Access

    Cryptosporidium lysyl-tRNA synthetase inhibitors define the interplay between solubility and permeability required to achieve efficacy

    by Nicola Caldwell, Caroline Peet, Peter Miller, Beatrice L. Colon, Malcolm G. Taylor, Mattia Cocco, Alice Dawson, Iva Lukac, Jose E. Teixeira, Lee Robinson, et al.

    Cryptosporidiosis is a diarrheal disease caused by infection with Cryptosporidium spp. parasites and is a leading cause of death in malnourished children worldwide. The only approved treatment, nitazoxanide, has limited efficacy in this at-risk patient population. Additional safe therapeutics are urgently required to tackle this unmet medical need. However, the development of anti-cryptosporidial drugs is hindered by a lack of understanding of the optimal compound properties required to treat this gastrointestinal infection. To address this knowledge gap, a diverse set of potent lysyl-tRNA synthetase inhibitors was profiled to identify optimal physicochemical and pharmacokinetic properties required for efficacy in a chronic mouse model of infection. The results from this comprehensive study illustrated the importance of balancing solubility and permeability to achieve efficacy in vivo. Our results establish in vitro criteria for solubility and permeability that are predictive of compound efficacy in vivo to guide the optimization of anti-cryptosporidial drugs. Two compounds from chemically distinct series (DDD489 and DDD508) were identified as demonstrating superior efficacy and prioritized for further evaluation. Both compounds achieved marked parasite reduction in immunocompromised mouse models and a disease-relevant calf model of infection. On the basis of these promising data, these compounds have been selected for progression to preclinical safety studies, expanding the portfolio of potential treatments for this neglected infectious disease.


  • Open Access

    Cryptosporidium Oocyst Wall Proteins are true oocyst wall proteins, with COWP8 functioning to hold the inner and outer layers of the oocyst wall together

    by Ross Bacchetti, Sarah Stevens, Leandro Lemgruber, Mariana Azevedo Gonzalez Oliva, Emma M Sands, Konstantinos Alexandrou, Michele Tinti, Lee Robinson, Jack C Hanna, Simona Seizova, et al.

    Cryptosporidiosis is a significant cause of diarrhoeal disease contributing to substantial morbidity and mortality for the immunocompromised and for young children, especially those who are malnourished. There are no vaccines available and no effective treatments for these patients. Another challenge is that Cryptosporidia are waterborne and resistant to common water treatments including chlorination. Cryptosporidia are transmitted as an oocyst that is made up of a hardy oocyst wall that protects four parasites. Little is understood about how the oocyst is constructed, its composition, and the how it resists chlorination. A family of predicted Cryptosporidium Oocyst Wall Proteins (COWPs) was identified from the genome. Using a genetic approach, we confirm that all members of the COWP family localise to the oocyst wall. Our studies indicate that COWP2, 3 and 4 localise specifically to the oocyst “suture”, a zipper-like structure on the oocyst wall from which parasites emerge during infection. In parasites lacking COWP8, we observe that the inner and outer layers of the oocyst wall are no longer associated suggesting a role for COWP8 in oocyst wall morphology. Despite loss of COWP8, these transgenic parasites are viable, unchanged in mechanical strength, and retain resistance to chlorination. This work sets the foundation for future exploration of Cryptosporidium transmission.

  • The first Cryptosporidium meeting: a concerted effort to fight cryptosporidiosis

    by Wes van Voorhis, Joyce Siwila, Jessica C. Kissinger, Natalia Bayona Vásquez, Guy Robinson, Rodrigo Baptista, Asis Khan, Amandine Guérin, Yi-Wei Chang, Zannatun Noor, et al.


  • Open Access

    Mode of action studies confirm on-target engagement of lysyl-tRNA synthetase inhibitor and lead to new selection marker for Cryptosporidium

    by Jack C. Hanna, Victor Corpas-Lopez, Simona Seizova, Beatrice L. Colon, Ross Bacchetti, Grant M. J. Hall, Emma M. Sands, Lee Robinson, Beatriz Baragaña, Susan Wyllie, et al.

    Introduction: Cryptosporidiosis is a leading cause of diarrheal-associated morbidity and mortality, predominantly affecting children under 5 years old in low-and-middle-income countries. There is no effective treatment and no vaccine. New therapeutics are emerging from drug discovery efforts. It is critical that mode of action studies are performed alongside drug discovery to ensure the best clinical outcomes. Unfortunately, technology to identify and validate drug targets for Cryptosporidium is severely lacking.Methods: We used C. parvum lysyl-tRNA synthetase (CpKRS) and DDD01510706 as a target-compound pair to develop both chemical and genetic tools for mode of action studies for Cryptosporidium. We adapted thermal proteome profiling (TPP) for Cryptosporidium, an unbiased approach for target identification.Results: Using TPP we identified the molecular target of DDD01510706 and confirm that it is CpKRS. Genetic tools confirm that CpKRS is expressed throughout the life cycle and that this target is essential for parasite survival. Parasites genetically modified to over-express CpKRS or parasites with a mutation at the compound-binding site are resistant to treatment with DDD01510706. We leveraged these mutations to generate a second drug selection marker for genetic modification of Cryptosporidium, KRSR. This second selection marker is interchangeable with the original selection marker, NeoR, and expands the range of reverse genetic approaches available to study parasite biology. Due to the sexual nature of the Cryptosporidium life cycle, parental strains containing different drug selection markers can be crossed in vivo.Discussion: Selection with both drug markers produces highly efficient genetic crosses (>99% hybrid progeny), paving the way for forward genetics approaches in Cryptosporidium.


  • Top Cited Papers

    A One Health Approach to Tackle Cryptosporidiosis

    by Elisabeth A. Innes, Rachel M. Chalmers, Beth Wells, Mattie C. Pawlowic